-
Signature
-
/s/ Melanie Vinson, Attorney-in-Fact
-
Issuer symbol
-
CFLT
-
Transactions as of
-
13 Feb 2025
-
Net transactions value
-
-$2,476,193
-
Form type
-
4
-
Filing time
-
18 Feb 2025, 19:00:14 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CFLT |
Class A Common Stock |
Conversion of derivative security |
|
+56,000 |
+11% |
|
588,623 |
13 Feb 2025 |
Direct |
F1 |
| transaction |
CFLT |
Class A Common Stock |
Sale |
$831,267 |
-23,110 |
-3.9% |
$35.97 |
565,513 |
13 Feb 2025 |
Direct |
F2, F3 |
| transaction |
CFLT |
Class A Common Stock |
Sale |
$1,644,926 |
-45,240 |
-8% |
$36.36 |
520,273 |
13 Feb 2025 |
Direct |
F2, F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CFLT |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-56,000 |
-38% |
$0.000000 |
91,813 |
13 Feb 2025 |
Class B Common Stock |
56,000 |
$7.34 |
Direct |
F5 |
| transaction |
CFLT |
Class B Common Stock |
Options Exercise |
$0 |
+56,000 |
|
$0.000000 |
56,000 |
13 Feb 2025 |
Class A Common Stock |
56,000 |
|
Direct |
F1 |
| transaction |
CFLT |
Class B Common Stock |
Conversion of derivative security |
$0 |
-56,000 |
-100% |
$0.000000 |
0 |
13 Feb 2025 |
Class A Common Stock |
56,000 |
|
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: